Format

Send to

Choose Destination
Leuk Lymphoma. 1999 Nov;35(5-6):641-2.

Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.

PMID:
10609806
DOI:
10.1080/10428199909169633
[Indexed for MEDLINE]

Publication types, MeSH terms, Substances, Supplementary concepts

Publication types

MeSH terms

Substances

Supplementary concepts

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center